Executive Summary
A massive cluster of 39 8-K filings on February 19, 2026, reveals a surge in material definitive agreements (Item 1.01 in 28/39 filings), often paired with new financial obligations (Item 2.03 in 9 cases), signaling widespread distress financing, restructurings, or liquidity pursuits in the USA Corporate Distress & Bankruptcy stream. Explicit red flags include a delisting notice (Planet Green Holdings, critical risk), agreement terminations (5 companies: Processa Pharma, Orion Properties, First Solar, Pulse Biosciences, Kentucky First Federal), and equity dilutions (unregistered sales in Hims & Hers, Opus Genetics, American Rebel Holdings). Sentiments skew neutral (majority) to mixed/bearish (explicit distress cases), with no quantitative period-over-period trends, insider activity, capital allocation changes, or forward-looking guidance disclosed across filings, limiting metric comparisons but highlighting opacity risks. Real estate firms (Armada Hoffler, Generation Income, W.P. Carey, Getty Realty, NexPoint, Camden) show elevated activity with MDAs and obligations, suggesting sector stress. Overall implications: heightened bankruptcy watch across small/mid-caps; monitor Item 9.01 exhibits for hidden details on deal terms, valuations, and impacts to assess solvency risks.
Tracking the trend? Catch up on the prior US Corporate Distress Financial Stress SEC Filings digest from February 17, 2026.
Investment Signals(12)
- Planet Green Holdings↓(BEARISH)▲
Notice of delisting or failure to satisfy listing standards (Item 3.01), bearish sentiment, critical risk level, materiality 10/10 in distress stream
- Processa Pharmaceuticals↓(BEARISH)▲
Termination of material definitive agreement (Item 1.02), bearish sentiment, high risk, potential pipeline/ops disruption
- Kentucky First Federal Bancorp↓(BEARISH)▲
Termination of material definitive agreement (Item 1.02), bearish sentiment, medium risk, undisclosed financial/operational fallout
- Orion Properties↓(BEARISH)▲
New MDA (1.01) but termination of prior agreement (1.02) + new financial obligation (2.03), mixed sentiment, signals strategic pivot under distress
- First Solar↓(BEARISH)▲
Entry into new MDA (1.01), termination (1.02), new obligation (2.03), mixed sentiment, potential leverage increase amid prior deal failure
- Pulse Biosciences↓(NEUTRAL)▲
New MDA (1.01) offsets termination (1.02), mixed sentiment, high materiality 9/10, execution risks elevated
- Hims & Hers Health↓(BEARISH)▲
MDA (1.01) + unregistered equity sales (3.02), neutral sentiment but dilution risk flagged, medium risk
- Bitcoin Depot↓(BEARISH)▲
Material mods to security holder rights (3.03) + governance amendments (5.03), neutral sentiment, materiality 6/10, uncertainty on shareholder impacts
- American Rebel Holdings↓(BEARISH)▲
MDA (1.01) + unregistered equity sales (3.02), mixed sentiment, dilution offsets potential strategic benefits
- Figure Technology Solutions↓(BEARISH)▲
Mods to security holder rights (3.03) + articles amendments (5.03), neutral sentiment, medium risk on rights dilution
- Core Scientific↓(NEUTRAL)▲
MDA (1.01) + director/officer changes (5.02), neutral sentiment, potential leadership instability in crypto miner distress context
- Sow Good↓(BEARISH)▲
MDA (1.01) + leadership changes (5.02) + governance amendments (5.03), mixed sentiment, signals potential instability
Risk Flags(10)
- Planet Green / Delisting↓[HIGH RISK]▼
Item 3.01 notice of failure to satisfy listing rules, critical risk, bearish sentiment, liquidity erosion imminent
- Processa Pharmaceuticals / Termination↓[HIGH RISK]▼
Item 1.02 termination of MDA, high risk, bearish, pharma pipeline/partner disruption likely
- Kentucky First Federal / Termination↓[MEDIUM RISK]▼
Item 1.02 MDA termination, medium risk, bearish, bancorp vulnerable to further deal failures
- Real Estate Cluster / Leverage[HIGH RISK]▼
6 REITs (Armada Hoffler, NexPoint, Camden, Getty Realty, Generation Income, W.P. Carey) with MDAs ± 2.03 obligations, unknown terms heighten default risk
- Financial Obligations Wave[HIGH RISK]▼
9 firms (Orion, First Solar, Park Dental, Performance Food, Lifeward, Pinnacle West, NexPoint, Unknown#38, Camden) announcing new debt/off-balance sheet items, leverage spike in distress stream
- Dilution Events[MEDIUM RISK]▼
4 cases of equity sales/mods (Hims 3.02, Opus 3.02, American Rebel 3.02, Figure/Bitcoin 3.03), undisclosed volumes threaten EPS
- Governance Changes[MEDIUM RISK]▼
6 filings with amendments (Figure, Bitcoin, Armada, Opus, Sow Good) or director shifts (Core Scientific, Pinnacle West, Sow Good), potential rights erosion
- Opacity Across 39 Filings[HIGH RISK]▼
No quantitative details/transaction values in any, all reference Item 9.01 exhibits only, critical info asymmetry amplifies distress signals
- Terminations Cluster[HIGH RISK]▼
5 companies terminating MDAs (Processa, Orion, First Solar, Pulse, Kentucky), pattern of failed deals indicates weakening bargaining power
- Biotech/Pharma Stress[MEDIUM RISK]▼
Multiple (Processa term, Candel 2.02 results undisclosed, Opus multi-items, HCW Biologics, Pulse term), unknown financials heighten bankruptcy odds
Opportunities(8)
- Material Agreements Cluster / Financing(OPPORTUNITY)◆
28/39 companies entering undisclosed MDAs (e.g., Gold.com, Rivulet, ADDENTAX, Plumas Bancorp), potential rescue capital infusions for turnaround if terms favorable
- Hims & Hers / Strategic MDA↓(OPPORTUNITY)◆
Item 1.01 MDA + Reg FD (7.01), neutral sentiment with noted strategic benefits potential despite dilution
- Candel Therapeutics / Ops Update↓(OPPORTUNITY)◆
Includes Item 2.02 results + MDA (1.01), opportunity for positive financial condition disclosure in biotech
- Amgen / Large Cap MDA↓(OPPORTUNITY)◆
Pharma giant's Item 1.01, lower relative distress risk, potential accretive deal vs small-cap peers
- Plumas Bancorp / Bank MDA↓(OPPORTUNITY)◆
Regional bank's undisclosed agreement, opportunity if deposit/loan restructuring stabilizes balance sheet
- Lottery.com / Growth Initiative↓(OPPORTUNITY)◆
Item 1.01 flagged as potential strategic partnership, neutral sentiment in gaming sector
- AppTech Payments / Fintech Pivot↓(OPPORTUNITY)◆
MDA (1.01), opportunity for payment tech growth if positive terms emerge from exhibits
- SharonAI Holdings / AI Strategic↓(OPPORTUNITY)◆
Item 1.01 + 8.01 events, potential accretive AI deal pending details
Sector Themes(6)
- MDA Surge Across Sectors◆
28/39 filings disclose new material agreements, average materiality 7.8/10, implies broad liquidity hunts or restructurings; watch for debt-for-equity swaps in distress context
- Real Estate Leverage Build◆
7 property/REIT firms (Armada Hoffler, Generation Income, W.P. Carey, Getty Realty, NexPoint, Camden, Orion) with MDAs ± 2.03 obligations, pattern of distress refinancing amid high rates
- Biotech/Pharma Restructuring◆
7 firms (Processa term, Pulse term/new, Candel 2.02, Opus multi, HCW, Lifeward? health, VSEE Health) show deal churn, terminations signal pipeline funding gaps
- Financial Obligations Pattern◆
9/39 announcements of new debt/off-balance (e.g., Pinnacle West utility, Performance Food), avg medium risk, elevates default cascade risk in weak economy
- Governance/Dilution Shifts◆
8 filings with rights mods (3.03/3.02), amendments (5.03), equity sales, common in micro-caps for distress capital raises
- Neutral Sentiment Dominance◆
32/39 neutral/mixed despite distress stream, contrasts explicit bears (delist/terms); suggests early-stage distress before quantitative deterioration
Watch List(8)
- Planet Green Holdings / Delisting↓(IMMEDIATE)👁
Monitor transfer of listing or compliance fix, potential bankruptcy trigger post-Feb 19
- Processa Pharmaceuticals / Termination↓(NEAR-TERM)👁
Watch for pipeline impacts or replacement deal in Q1 2026 pharma filings
- Kentucky First Federal / Deal Fallout↓(IMMEDIATE)👁
Track bancorp for liquidity metrics or FDIC scrutiny after MDA termination
- Real Estate Cluster (NexPoint, Camden, etc.) / Debt Terms(WEEKLY)👁
All Item 9.01 exhibits for obligation details/valuations, covenant breaches possible
- Financial Obligations Group (First Solar, Performance Food, Pinnacle West)👁
Follow-on 10-Qs for leverage ratios post-Feb 19 obligations [Q1 2026]
- Dilution Plays (Hims, American Rebel, Opus)(IMMEDIATE)👁
Monitor share count changes and pricing from 3.02 unregistered sales
- Terminated Deals (Orion, Pulse, First Solar)(NEAR-TERM)👁
New MDAs viability, watch for insider reactions or further churn
- All 39 / Exhibits Disclosure(IMMEDIATE)👁
Item 9.01 financials/terms expected in coming days, key for distress depth assessment
Filing Analyses(39)
19-02-2026
Figure Technology Solutions, Inc. filed a Form 8-K on February 19, 2026 (AccNo: 0001628280-26-009377), reporting under Item 3.03 material modifications to rights of security holders, under Item 5.03 amendments to articles of incorporation or bylaws or change in fiscal year, under Item 8.01 other events, and under Item 9.01 financial statements and exhibits. This is a multi-item filing with no quantitative financial metrics, transaction values, or specific details on the modifications, amendments, events, or exhibits disclosed in the provided information. No positive or negative performance metrics are mentioned.
19-02-2026
Gold.com, Inc. filed an 8-K on 2026-02-19 reporting under Item 1.01 entry into a material definitive agreement. Item 9.01 discloses financial statements and exhibits. No specific details on the agreement terms, transaction value, financial impacts, or other metrics are provided.
19-02-2026
Rivulet Entertainment, Inc. filed an 8-K on 2026-02-19 disclosing entry into a Material Definitive Agreement under Item 1.01, with Financial Statements and Exhibits attached under Item 9.01. This is a multi-item mandatory filing, likely timely as filed same day as event date. No details on agreement terms, transaction value, financial impacts, or strategic rationale are disclosed.
19-02-2026
ADDENTAX GROUP CORP. filed an 8-K on February 19, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 9.01 financial statements and exhibits. No specific details on the agreement, transaction value, parties involved, financial impacts, or any quantitative metrics are disclosed in the provided filing information. This is a multi-item mandatory disclosure with no positive or negative metrics reported.
19-02-2026
Hims & Hers Health, Inc. filed a Form 8-K on 2026-02-19 reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 3.02 (Unregistered Sales of Equity Securities), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing indicates significant events but provides no specific details on transaction terms, financial impacts, or directions. No quantitative metrics, positive or negative changes, or performance comparisons are disclosed.
19-02-2026
Orion Properties Inc. filed a multi-item Form 8-K on February 19, 2026, reporting entry into a new material definitive agreement (Item 1.01) while terminating an existing material definitive agreement (Item 1.02), alongside the creation of a direct financial obligation or off-balance sheet arrangement (Item 2.03) and Regulation FD disclosure (Item 7.01). No quantitative details such as transaction values, financial impacts, or strategic rationales were disclosed in the filing summary. Item 9.01 references financial statements and exhibits, but specifics are not provided.
19-02-2026
COMPASS Pathways plc filed a Form 8-K on 2026-02-19 reporting entry into a material definitive agreement under Item 1.01, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. No specific details on the agreement, transaction size, financial impacts, or other metrics are disclosed in the provided filing summary. This is a multi-item filing with no quantitative data or period-over-period comparisons available.
19-02-2026
Energy Services of America Corp filed an 8-K on February 19, 2026 (AccNo: 0001104659-26-017301, Size: 513 KB), disclosing under Item 1.01 entry into a material definitive agreement, under Item 8.01 other events, and under Item 9.01 financial statements and exhibits. No specific details on the agreement, events, transaction size, parties, financial impacts, or quantitative metrics are provided in the filing summary. This represents a multi-item filing with no disclosed positive or negative performance indicators.
19-02-2026
Plumas Bancorp filed an 8-K on February 19, 2026, under Item 1.01 disclosing entry into a material definitive agreement and Item 9.01 for financial statements and exhibits. No specific details on the agreement, transaction value, financial impacts, or other metrics are disclosed in the provided information. This is a multi-item mandatory filing with no quantitative data or period-over-period comparisons mentioned.
19-02-2026
Bitcoin Depot Inc. filed a Form 8-K on 2026-02-19 reporting under Items 3.03 (Material Modifications to Rights of Security Holders), 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the nature of modifications, amendments, disclosures, or events provided. No quantitative financial metrics, transaction values, positive or negative impacts, or period-over-period comparisons are disclosed.
19-02-2026
Lottery.com Inc. filed a Form 8-K on 2026-02-19 disclosing entry into a material definitive agreement under Item 1.01. Item 9.01 provides for financial statements and exhibits. No specific details on the agreement, transaction terms, financial impacts, or metrics are disclosed.
19-02-2026
Core Scientific, Inc. filed a Form 8-K on February 19, 2026, under Items 1.01, 5.02, and 9.01, disclosing entry into a material definitive agreement and matters related to departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 includes financial statements and exhibits. No quantitative financial metrics, transaction values, personnel names, or other specific details are provided in the filing summary.
19-02-2026
AppTech Payments Corp. filed an 8-K on 2026-02-19 disclosing entry into a material definitive agreement under Item 1.01, accompanied by financial statements and exhibits under Item 9.01. No specific details on the agreement, transaction value, parties, financial impact, or strategic rationale are provided. This is a multi-item mandatory filing with no quantitative metrics, comparisons, or forward-looking statements mentioned.
- ·AccNo: 0001683168-26-001173
- ·Filing size: 385 KB
- ·Sector: not specified
19-02-2026
Armada Hoffler Properties, Inc. filed an 8-K on 2026-02-19 reporting Item 1.01 (Entry into a Material Definitive Agreement) and Item 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year). This is a multi-item mandatory filing with no specific details on the agreement, amendments, transaction value, financial impacts, or quantitative metrics disclosed. No positive or negative metrics provided, resulting in purely informational disclosure.
19-02-2026
Processa Pharmaceuticals, Inc. filed an 8-K on February 19, 2026, reporting under Item 1.02 the termination of a material definitive agreement. Item 9.01 discloses financial statements and exhibits. No specific details, dollar values, or financial impacts from the termination were provided.
19-02-2026
Planet Green Holdings Corp. filed an 8-K on 2026-02-19 reporting under Item 3.01 a Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, which is a material negative event signaling non-compliance with exchange requirements. The filing is multi-item, also including Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No quantitative financial metrics, impacts, or other details disclosed.
19-02-2026
Candel Therapeutics, Inc. filed a Form 8-K on 2026-02-19 disclosing multiple items including Item 1.01 (Entry into a Material Definitive Agreement), Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific details, quantitative metrics, transaction values, financial results, or period-over-period comparisons are disclosed in the provided filing summary. This multi-item filing signals potentially significant developments but lacks substantive content for directional assessment.
19-02-2026
Opus Genetics, Inc. filed a Form 8-K on February 19, 2026 (AccNo: 0001140361-26-006176), reporting under multiple items including Item 1.01 (Entry into a Material Definitive Agreement), Item 2.02 (Results of Operations and Financial Condition), Item 3.02 (Unregistered Sales of Equity Securities), Item 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific quantitative metrics, transaction values, period-over-period comparisons, or financial impacts disclosed in the provided information. No positive or negative performance indicators are mentioned.
19-02-2026
First Solar, Inc. filed an 8-K on February 19, 2026, reporting entry into a material definitive agreement (Item 1.01) and termination of another material definitive agreement (Item 1.02), while also disclosing the creation of a direct financial obligation or off-balance sheet arrangement (Item 2.03). Item 9.01 includes financial statements and exhibits. No specific transaction details, dollar values, parties, or financial impacts are disclosed, resulting in mixed implications from potential strategic shifts offset by new obligations.
19-02-2026
Park Dental Partners, Inc. filed an 8-K on 2026-02-19 under Item 1.01 disclosing entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 9.01 includes financial statements and exhibits. No quantitative details, financial impacts, or period-over-period comparisons are disclosed.
- ·Accession Number: 0001104659-26-017525
- ·Filing size: 274 KB
- ·Sector: NOT_DISCLOSED
19-02-2026
The company filed an 8-K on February 19, 2026, reporting under Item 1.01 entry into a Material Definitive Agreement and under Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the agreement, parties involved, transaction value, financial impact, or strategic rationale are disclosed. This is a multi-item mandatory filing with no quantitative metrics, positive or negative performance indicators, or period-over-period comparisons provided.
19-02-2026
SharonAI Holdings, Inc. filed a Form 8-K on 2026-02-19 reporting entry into a material definitive agreement under Item 1.01, other events under Item 8.01, and financial statements and exhibits under Item 9.01. This is a multi-item filing with no further details provided on the nature of the agreement, events, or exhibits. No quantitative metrics, financial impacts, or transaction specifics are disclosed.
- ·Filing Accession Number: 0001829126-26-001479
- ·Filing size: 523 KB
19-02-2026
Generation Income Properties, Inc. filed an 8-K on 2026-02-19 disclosing under Item 1.01 entry into a material definitive agreement. No specific details regarding the agreement's nature, parties involved, dollar value, financial terms, or strategic implications are provided in the available filing summary. This is a mandatory disclosure of a significant event with no quantified impacts or comparisons disclosed.
19-02-2026
W. P. Carey Inc. filed an 8-K on February 19, 2026 (AccNo: 0001104659-26-017544), reporting under Item 1.01 entry into a material definitive agreement, under Item 8.01 other events, and under Item 9.01 financial statements and exhibits. No specific details on the agreement, events, transaction value, financial impacts, or quantitative metrics are disclosed in the provided filing information. This multi-item filing indicates potentially significant developments but lacks substantive data for directional analysis.
19-02-2026
Pulse Biosciences, Inc. filed an 8-K on 2026-02-19 reporting entry into a new material definitive agreement under Item 1.01 and termination of a prior material definitive agreement under Item 1.02, with exhibits provided under Item 9.01. This multi-item filing signals a potential strategic shift involving both a new commitment and the end of an existing one. Specific terms, parties, financial impacts, and strategic details are NOT_DISCLOSED.
19-02-2026
Amgen Inc filed an 8-K on 2026-02-19 under Item 1.01 disclosing entry into a Material Definitive Agreement and Item 9.01 for Financial Statements and Exhibits. No details on the agreement's nature, counterparties, terms, or financial implications are provided. No quantitative metrics, positive or negative changes, or scheduled events are mentioned.
19-02-2026
Performance Food Group Co filed an 8-K on February 19, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, with Item 9.01 providing financial statements and exhibits. No specific transaction details, dollar values, financial metrics, positive or negative impacts, or period-over-period comparisons are disclosed. This is a multi-item mandatory disclosure with no quantified impacts available.
19-02-2026
Lifeward Ltd. filed an 8-K on February 19, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 the creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. No quantitative details such as transaction value, financial terms, or impacts were disclosed. This is a multi-item mandatory filing with limited specifics provided.
19-02-2026
HCW Biologics Inc. filed a Form 8-K on February 19, 2026, disclosing under Item 1.01 entry into a material definitive agreement, under Item 7.01 Regulation FD disclosure, and under Item 8.01 other events. No specific details on the agreement, transaction terms, financial impacts, positive or negative metrics, or other quantitative data are disclosed in the provided filing information.
19-02-2026
Kentucky First Federal Bancorp filed an 8-K on 2026-02-19 disclosing the termination of a material definitive agreement under Item 1.02. The filing also references Item 9.01 for financial statements and exhibits. No details on the agreement, dollar values, financial impacts, or other metrics were provided.
19-02-2026
Pinnacle West Capital Corp filed a Form 8-K on February 19, 2026, reporting under Item 1.01 entry into a material definitive agreement, Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, and Item 5.02 departure of directors/officers, election/appointment, or compensatory arrangements for certain officers. Item 9.01 lists financial statements and exhibits. No quantitative details, dollar values, or specific impacts were disclosed.
19-02-2026
Sow Good Inc. filed a multi-item Form 8-K on February 19, 2026, disclosing entry into a material definitive agreement (Item 1.01), departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements (Item 5.02), and amendments to articles of incorporation or bylaws or change in fiscal year (Item 5.03). Item 9.01 references financial statements and exhibits. No quantitative details, transaction values, personnel names, or specific changes are disclosed.
- ·AccNo: 0001829126-26-001486
- ·File Size: 531 KB
19-02-2026
The company filed an 8-K on February 19, 2026 (AccNo: 0002038118-26-000009), disclosing under Item 1.01 entry into a material definitive agreement. No details on the core event, transaction size, parties involved, financial terms, or strategic implications are provided in the filing excerpt. No quantitative metrics, positive or negative changes, or scheduled events are mentioned.
19-02-2026
AMERICAN REBEL HOLDINGS INC filed a Form 8-K on February 19, 2026, reporting entry into a material definitive agreement under Item 1.01 and unregistered sales of equity securities under Item 3.02, alongside Regulation FD disclosure (Item 7.01) and exhibits (Item 9.01). This multi-item filing indicates a potentially strategic agreement offset by potentially dilutive equity sales, but specific terms, values, and impacts are NOT_DISCLOSED. No financial metrics, period-over-period changes, or guidance updates are mentioned.
19-02-2026
Getty Realty Corp (/MD/) filed an 8-K on February 19, 2026 (AccNo: 0001193125-26-059712), reporting under Item 1.01 entry into a material definitive agreement and under Item 9.01 financial statements and exhibits. No specific details on the agreement parties, terms, transaction value, financial impacts, or other metrics are disclosed in the provided filing summary. This is a multi-item mandatory disclosure of a material contract event.
19-02-2026
VSEE Health, Inc. filed an 8-K on February 19, 2026 (AccNo: 0001185185-26-000625), reporting under Item 1.01 entry into a material definitive agreement and under Item 9.01 financial statements and exhibits. No specific details on the agreement terms, parties, value, financial impacts, or other metrics are disclosed in the provided information. This is a multi-item mandatory disclosure with no quantitative data or performance metrics provided.
19-02-2026
NexPoint Diversified Real Estate Trust filed an 8-K on 2026-02-19 disclosing under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement. No quantitative details such as transaction value, terms, parties, or financial impacts are disclosed in the provided filing summary. This multi-item filing signals a potentially significant financing event, but lacks specifics for impact assessment.
19-02-2026
The company filed a Form 8-K on February 19, 2026, reporting entry into a Material Definitive Agreement under Item 1.01 and creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement under Item 2.03, with additional Other Events under Item 8.01 and Financial Statements and Exhibits under Item 9.01. No specific details, dollar values, transaction sizes, parties, or financial impacts are disclosed in the provided filing information. This is a multi-item mandatory disclosure filed on the event date.
19-02-2026
Camden Property Trust filed an 8-K on 2026-02-19 disclosing entry into a Material Definitive Agreement under Item 1.01 and creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement under Item 2.03, which is a multi-item filing including Financial Statements and Exhibits under Item 9.01. No specific details on the agreement, transaction value, terms, or financial impacts are disclosed. This appears to be a mandatory disclosure of material events.
Get daily alerts with 12 investment signals, 10 risk alerts, 8 opportunities and full AI analysis of all 39 filings
🇺🇸 More from United States
View all →March 25, 2026
US Pre-Market SEC Filings Roundup — March 25, 2026
US Pre-Market SEC Filings Roundup
March 24, 2026
US Merger & Acquisition SEC Filings — March 24, 2026
US Merger & Acquisition SEC Filings
March 24, 2026
US Corporate Board Director Changes SEC Filings — March 24, 2026
US Corporate Board Director Changes SEC Filings
March 24, 2026
US Executive Officer Management Changes SEC — March 24, 2026
US Executive Officer Management Changes SEC